EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Diagnostic utility of speech-based biomarkers in mild cognitive impairment: a systematic review and meta-analysis

Zahra Jafari iD, Melissa K Andrew iD, Kenneth J Rockwood

Age and Ageing · 29.08.2025 · 54 (10)

DOI: 10.1093/ageing/afaf316 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Age and Ageing, online erschienen am 28.10.2025. Verfasst von Zahra Jafari und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Communication Sciences and Disorders, Dalhousie University, Halifax, Nova Scotia, Canada. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Speech. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Among various tools developed for mild cognitive impairment (MCI) detection, analysing speech features is a non-invasive and cost-effective approach that shows promise for early detection. This review aimed to systematically synthesise and analyse current evidence on the diagnostic utility of speech-based biomarkers for identifying MCI.

Methods

A systematic review and meta-analysis were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Scopus, Ovid Medline and PsycINFO databases were searched up to April 2025 without restrictions on language, article status or year.

Results

Of 4432 identified records, 54 peer-reviewed articles met the inclusion criteria. Fixed-effects meta-analyses showed pooled estimates of 80.0% ‘accuracy’ [95% confidence intervals (CI): 70.0%–89.0%, P < .001, n = 21], 78.0% ‘area under the curve’ (95% CI: 70.0%–86.0%, P < .001, n = 21), 80.0% ‘sensitivity’ (95% CI: 71.0%–90.0%, P < .001, n = 22), and 77.0% ‘specificity’ (95% CI: 65.0%–89.0%, P < .001, n = 15) in differentiating MCI from cognitively unimpaired (CU) individuals. Egger’s regression tests indicated no publication bias (P ≥ .299), and the I2 statistic revealed no heterogeneity across studies (I2 = 0.00%, P = 1.00). Four studies also included a subjective cognitive decline group, reporting significant differences in certain speech features compared to CU.

Conclusions

Speech analysis demonstrates moderate classification performance, with balanced sensitivity and specificity, in distinguishing MCI from CU, suggesting its potential as an accurate and cost-effective diagnostic tool for MCI detection. Further research is needed to address variations in study methodologies, refine speech analysis protocols and validate findings in diverse populations to enhance generalisability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionSpeechHumansBiomarkers

Stichwörter der Autor:innen

accuracyautomatic speech recognitionmachine learningmild cognitive impairmentolder adultssensitivityspecificityspeech analysissubjective cognitive declinesystematic review

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Communication Sciences and Disorders, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Geriatric Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Otolaryngology - Head & Neck Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Psychology and Neuroscience, Dalhousie University, Halifax, Nova Scotia, Canada.

ORCID-Profile: Zahra Jafari, Melissa K Andrew

Zitieren

APA

Jafari, Z., Andrew, M. K., & Rockwood, K. J. (2025). Diagnostic utility of speech-based biomarkers in mild cognitive impairment: a systematic review and meta-analysis. Age and Ageing, 54(10). https://doi.org/10.1093/ageing/afaf316

Vancouver

Jafari Z, Andrew MK, Rockwood KJ. Diagnostic utility of speech-based biomarkers in mild cognitive impairment: a systematic review and meta-analysis. Age and Ageing. 2025;54(10). doi:10.1093/ageing/afaf316

BibTeX
@article{Jafari2025,
  author = {Jafari, Zahra and Andrew, Melissa K and Rockwood, Kenneth J},
  title = {Diagnostic utility of speech-based biomarkers in mild cognitive impairment: a systematic review and meta-analysis},
  journal = {Age and Ageing},
  year = {2025},
  volume = {54},
  number = {10},
  doi = {10.1093/ageing/afaf316}
}
Kostenlos starten →